Clinical Profile and Therapeutic Outcomes in Substance Use Disorders: A Hospital-Based Prospective Study

Background: Substance use disorder (SUD) is a growing global challenge, leading to severe health, social, and economic consequences [1,2]. This study aims to assess the clinical profiles, treatment outcomes, and comorbidities in patients presenting with substance use disorder.Methods: A hospital-based study was conducted with 139 patients diagnosed with substance use disorders, including alcohol, opioid, cannabis, and tobacco users. Data were collected using structured interviews and validated clinical scales such as the Alcohol Dependence Scale (ADS), Clinical Institute Withdrawal Assessment Scale (CIWA-Ar), and the Fagerstrom Test for Nicotine Dependence (FTND) [3-5]. Patients were followed up for therapeutic outcomes over a period of one year [6].

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-26
DOI
https://doi.org/10.5281/zenodo.13995896
Primary Topic
Substance Abuse Treatment and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Profile and Therapeutic Outcomes in Substance Use Disorders: A Hospital-Based Prospective Study

Zenodo (CERN European Organization for Nuclear Research)
Substance Abuse Treatment and Outcomes
article

Clinical Profile and Therapeutic Outcomes in Substance Use Disorders: A Hospital-Based Prospective Study

article en

Abstract

Background: Substance use disorder (SUD) is a growing global challenge, leading to severe health, social, and economic consequences [1,2]. This study aims to assess the clinical profiles, treatment outcomes, and comorbidities in patients presenting with substance use disorder.Methods: A hospital-based study was conducted with 139 patients diagnosed with substance use disorders, including alcohol, opioid, cannabis, and tobacco users. Data were collected using structured interviews and validated clinical scales such as the Alcohol Dependence Scale (ADS), Clinical Institute Withdrawal Assessment Scale (CIWA-Ar), and the Fagerstrom Test for Nicotine Dependence (FTND) [3-5]. Patients were followed up for therapeutic outcomes over a period of one year [6].

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 56%
Substance Abuse Treatment and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.